Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

businesswire.com
AVNS

ADMA DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

globenewswire.com
ADMA

Ethlabs, fondata da ex collaboratori della Ethereum Foundation e finanziata da Bitmine, Sharplink e Joe Lubin, viene lanciata per accelerare il superciclo istituzionale di Ethereum

prnewswire.com
SBET BMNR

Click Bond Welcomes Nathan Delgleize as New VP, Finance

prnewswire.com
LHX IBM

EShallGo Inc. Announces Pricing of $1.479 Million Registered Direct Offering

globenewswire.com
EHGO

GRAL LAWSUIT ALERT: Levi & Korsinsky Notifies GRAIL, Inc. Investors - Lead Plaintiff Deadline August 4, 2026

accessnewswire.com
GRAL

Lucid Group, Inc. (LCID) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before July 28, 2026

accessnewswire.com
LCID

Shareholders of Verra Mobility Corporation (VRRM): Protect Your Rights Before August 4, 2026 - Contact Levi & Korsinsky

accessnewswire.com
VRRM

Corning Announces Quarterly Dividend

businesswire.com
GLW

Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRX

businesswire.com
CPRX
View all news →